Katz Barrett
- SEC CIK
- 0001841628
No open-market purchases or sales filed in the past year.
Current role at each company
- VRDN Viridian Therapeutics, Inc.Chief Medical Officeras of Feb 10, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Katz Barrett as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 18, 2023 (view filing) | Jan 13-17 | 5 days | Katz BarrettChief Medical Officer | SSale | −29.0K | $37.18 | −$1.08M | −100.0%0 after | 2 lots |
| Jan 11, 2023 (view filing) | Jan 9-10 | 2 days | Katz BarrettChief Medical Officer | SSale | −60.0K | $34.82 | −$2.09M | −100.0%0 after | 2 lots |